B_table indent_3.5 mm N_table indent_3 mm 维亚生物科技控股集团 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take 用简体 no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. 李向荣 _荣字用简体 (Incorporated in the Cayman Islands as an exempted company with limited liability) (Stock code: 1873) CLARIFICATION ANNOUNCEMENTReference is made to the third amended and restated memorandum of association (“Third Amended andRestated Memorandum”) and articles of association (the “Third Amended and Restated Articles”together with the Third Amended and Restated Memorandum the “Third Amended and RestatedM&A”) of Viva Biotech Holdings (the “Company”) published on June 26 2024.The Company is aware of a clerical error contained in the Third Amended and Restated Articles previously published and would like to clarify as follows:The title of the Third Amended and Restated Articles should read “THIRD SECOND AMENDED ANDRESTATED ARTICLES OF ASSOCIATION OF VIVA BIOTECH HOLDINGS 维亚生物科技控股集团 ”. In addition certain margin notes references appearing on pages 22 and 50 of the Third Amended and Restated Articles as well as margin note references appear on page 26 of the Chinese translation to the Third Amended and Restated Articles would also be updated to aid review of the document.Save for the aforementioned all other contents of the Third Amended and Restated M&A shall remain unchanged.By order of the Board VIVA BIOTECH HOLDINGS Mao Chen Cheney Chairman and Executive Director Hong Kong July 3 2024 As at the date of this announcement the Board comprises three Executive Directors namely Mr. Mao Chen Cheney (Chairman) Mr. WU Ying and Mr. Ren Delin; two Non-executive Directors namely Mr. WU Yuting and Mr. Wang Stephen Hui; and three Independent Non-executive Directors namely Mr. Fu Lei Ms. Li Xiangrong and Mr. Wang Haiguang.